Intradermal injection

DEVICE6 trials

Sponsors

Massachusetts General Hospital, Ataturk University, Al-Azhar University, Dhurakij Pundit University, Laboratoires FILLMED

Conditions

Alopecia AreataEnlarged PoresMigraine HeadacheSkin AgingSkin WrinklingsType 1 Diabetes

Early Phase 1

Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP

CompletedNCT05251831

Al-Azhar UniversityAlopecia Areata

Start: 2020-02-01End: 2021-03-30Updated: 2022-02-23

Phase 2

Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes

Massachusetts General HospitalType 1 Diabetes

Start: 2012-08-31End: 2017-12-31Target: 20Updated: 2016-09-07

Phase 3

Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores

Active, not recruitingNCT06293755

Dhurakij Pundit UniversityEnlarged Pores

Start: 2024-02-28End: 2024-06-25Target: 16Updated: 2024-03-05

Unknown Phase

Mesotherapy Versus Systemic Therapyin Treatment of Migraine Headache

CompletedNCT04519346

Ataturk UniversityMigraine Headache

Start: 2019-12-01End: 2020-05-01Updated: 2020-08-19

Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study

CompletedNCT07007351

Laboratoires FILLMEDSkin Aging

Start: 2023-03-19End: 2024-06-13Updated: 2025-06-05

Regenarative Treatment of Periocular Wrinkles With PDRN

RecruitingNCT07280637

University of TaubateSkin Wrinklings

Start: 2025-11-30End: 2026-08-30Target: 25Updated: 2025-12-18

Related Papers

Intradermal mesotherapy versus intravenous dexketoprofen for the treatment of migraine headache without aura: a randomized controlled trial

Annals of Saudi Medicine2021-06-0111 citations